Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
84 participants
INTERVENTIONAL
2007-04-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients with acute exacerbation of COPD (AECOPD)and diabetes treated with insulin had a longer in-patient stay and more frequent isolation of Gram negative bacteria from sputum than those without diabetes.Hyperglycemia (\>11 mmol/l) on admission predicted failure of non-invasive ventilation and infectious pulmonary complications in patients admitted to the ICU with acute respiratory failure caused by severe AECOPD.
The primary goal of this study is to test the hypothesis that in AECOPD, tight glycemic control during hospital stay will improve outcome of hospitalization.
The secondary goal of this study is to test new ways in controlling patients in the internal medicine ward.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on COPD Corticosteroid-induced Hyperglycemia on Clinical Outcome in Patients With COPD
NCT00605007
Phase II Study of Safety and Feasibility of Intensive Blood Glucose Control With Insulin on Acute Medical Wards
NCT00764556
Hyperglycemia and Mitochondrial Function in The Endothelium of Humans
NCT02682342
Pre-admission Hyperglycemia and Its Effect on Morbidity and Mortality
NCT00871832
Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology Patients
NCT02012465
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tight insulin treatment in patients hospitalized with COPD exacerbation
treatment with basal plus bolus insulin
tight glycemic control
treatment with basal and bolus insulin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with COPD be ATS criteria
* hospitalized with acute exacerbation, 2/3 criteria:1- worsening of SOB 2-change in sputum volume 3- change in sputum color
* signed informed concent
Exclusion Criteria
* pneumonia
* pneumothorax
* bronchiectasis
* lung collapse
* congestive heart failure
* lung cancer
* suspected pulmonary emboli
* immune deficiency (acquired 0r congenital)
* cystic fibrosis
* post lung implantation
* asthma/ non smokers
45 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Soroka University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Idit F Liberty
Dr Idit Liberty MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Idit F Liberty
Role: PRINCIPAL_INVESTIGATOR
Soroka University Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
sor450807ctil
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.